Paredes, Daniel A PHD
University of Denver
University of Denver
Early onset Alzheimer's disease occurs in eighty percent of individuals with Down syndrome with few therapeutic options available. This study provides the opportunity to use the polyamine pathway as a potential drug target that could be a contributing factor in the development of neuropathology underlying dementia in Down syndrome.